AIDS In The USA: People, Papers, And Funding

“Better late than never,” one might say about the U.S. federal government’s response to AIDS, first identified in 1981. Only in the past few years has the government moved aggressively to fund the battle against the epidemic. Today, al- though federal funding has greatly increased, many continue to believe that it is still below what it should be. In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the

Written byDavid Pendlebury
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the then-current research budget for AIDS, which stood at close to half a billion dollars. That goal may now be in sight. Federal outlays for fiscal year 1988 will likely approach between $1 billion and $1.5 billion, which is the appropriated sum. And the president’s request for fiscal year 1989 is for $2.2 billion. Naylor now says, “We are beginning to approach levels of spending that could be considered maximally effective, given the available talent pool of researchers and technicians.” But he quickly adds, “It is important, however, that the government continue its commitment for more than the short term.”

The accompanying chart brings together three sets of data: (a) the number of diagnosed cases of AIDS per year since 1982; (b) the number of AIDS articles with at least ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform